A Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

计划入组 6 人 · 首次发布于 2017 年 9 月 11 日

A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1

计划入组 120 人 · 首次发布于 2025 年 9 月 18 日

Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy

计划入组 21 人 · 首次发布于 2015 年 12 月 11 日

AGB1

AGEN-2373

AGEX-iTR1547

Nemocnice AGEL Třinec-Podlesí a.s.

Czech Republic

NEW AGE VENTURES LLC

United States

Transgene and ProBioGen Expand Strategic Partnership with Additional License for AGE1.CR.pIX Cell Line

Aerska Secures $39M Series A to Advance RNA Brain Delivery Platform for Neurological Diseases

Aperture Therapeutics Advances CD33-Targeting Antisense Oligonucleotide APRTX-001 for Neurodegenerative Diseases